Cv Sciences Stock Performance
| CVSI Stock | USD 0.06 0 5.00% |
CV Sciences holds a performance score of 7 on a scale of zero to a hundred. The firm owns a Beta (Systematic Risk) of 1.78, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, CV Sciences will likely underperform. Use CV Sciences coefficient of variation, semi variance, period momentum indicator, as well as the relationship between the treynor ratio and daily balance of power , to analyze future returns on CV Sciences.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in CV Sciences are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite fairly fragile basic indicators, CV Sciences demonstrated solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 4.5 M | |
| Total Cashflows From Investing Activities | -35 K |
CVSI |
CV Sciences Relative Risk vs. Return Landscape
If you would invest 4.00 in CV Sciences on October 11, 2025 and sell it today you would earn a total of 1.70 from holding CV Sciences or generate 42.5% return on investment over 90 days. CV Sciences is currently generating 1.9671% in daily expected returns and assumes 19.8518% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than CVSI, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
CV Sciences Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for CV Sciences' investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as CV Sciences, and traders can use it to determine the average amount a CV Sciences' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0991
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | CVSI | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average CV Sciences is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of CV Sciences by adding it to a well-diversified portfolio.
CV Sciences Fundamentals Growth
CVSI OTC Stock prices reflect investors' perceptions of the future prospects and financial health of CV Sciences, and CV Sciences fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on CVSI OTC Stock performance.
| Return On Equity | -2.36 | |||
| Return On Asset | -0.52 | |||
| Profit Margin | (0.85) % | |||
| Operating Margin | (0.93) % | |||
| Current Valuation | 5.53 M | |||
| Shares Outstanding | 150.1 M | |||
| Price To Earning | 54.89 X | |||
| Price To Book | 3.57 X | |||
| Price To Sales | 0.28 X | |||
| Revenue | 20.05 M | |||
| EBITDA | (14.35 M) | |||
| Cash And Equivalents | 1.11 M | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 1.4 M | |||
| Debt To Equity | 0.74 % | |||
| Book Value Per Share | 0.01 X | |||
| Cash Flow From Operations | (7.49 M) | |||
| Earnings Per Share | (0.13) X | |||
| Total Asset | 18.07 M | |||
| Retained Earnings | (21.65 M) | |||
| Current Asset | 15.84 M | |||
| Current Liabilities | 3.01 M | |||
About CV Sciences Performance
By evaluating CV Sciences' fundamental ratios, stakeholders can gain valuable insights into CV Sciences' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if CV Sciences has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if CV Sciences has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
CV Sciences, Inc. operates as a life science company in North America. CV Sciences, Inc. was incorporated in 2010 and is based in San Diego, California. Cv Sciences operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 69 people.Things to note about CV Sciences performance evaluation
Checking the ongoing alerts about CV Sciences for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for CV Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| CV Sciences is way too risky over 90 days horizon | |
| CV Sciences has some characteristics of a very speculative penny stock | |
| CV Sciences appears to be risky and price may revert if volatility continues | |
| CV Sciences currently holds 1.4 M in liabilities with Debt to Equity (D/E) ratio of 0.74, which is about average as compared to similar companies. CV Sciences has a current ratio of 0.91, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist CV Sciences until it has trouble settling it off, either with new capital or with free cash flow. So, CV Sciences' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like CV Sciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for CVSI to invest in growth at high rates of return. When we think about CV Sciences' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 20.05 M. Net Loss for the year was (15.55 M) with profit before overhead, payroll, taxes, and interest of 8.62 M. | |
| CV Sciences currently holds about 1.11 M in cash with (7.49 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. |
- Analyzing CV Sciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether CV Sciences' stock is overvalued or undervalued compared to its peers.
- Examining CV Sciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating CV Sciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of CV Sciences' management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of CV Sciences' otc stock. These opinions can provide insight into CV Sciences' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for CVSI OTC Stock analysis
When running CV Sciences' price analysis, check to measure CV Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CV Sciences is operating at the current time. Most of CV Sciences' value examination focuses on studying past and present price action to predict the probability of CV Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CV Sciences' price. Additionally, you may evaluate how the addition of CV Sciences to your portfolios can decrease your overall portfolio volatility.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |